Chronic Hepatitis C
HEPATITIS C --- Navigation Topics
Top New Articles on HCV
All HCV Articles by Topic ( A to Z )
HCV Basics
HIV-HCV Coinfection
FDA-approved Treatments for HCV
- Roferon A (interferon alfa-2a)
- Intron A (interferon alfa-2b)
- Infergen (consensus interferon)
- Pegasys (peginterferon alfa-2a)
- PegIntron (peginterferon alfa-2b)
- Copegus / Rebetol (ribavirin)
- Intron A + Rebetol
- Roferon A + Ribavirin
- Pegasys + Copegus
- PegIntron + Rebetol
Treatment Guidelines for HCV
Experimental Treatments for HCV
Recent Research Conference Reports
Tests for HCV
Liver-related Complications
Drug-related Adverse Events
Doctor Is In 'Q and A' for HCV
Library of CME Programs
E-mail Update - Sign Up
About Us - Contact Us
_______________
Platelets / Thrombocytopenia
Predicting Cirrhosis in Patients with Hepatitis C Based on Use of Standard Laboratory Tests
- 7/18/05
Suppression of
Blood Cell Formation
during Chronic Hepatitis C Therapy with Different Interferon Alfa Mono- and Combination Therapy Regimens
- 7/15/05
Effects of Therapy with Interferon Alfa and Pegylated Interferon Alfa/Ribavirin on
Platelet
Plug Formation and von Willebrand Factor Release in Patients with
Chronic Hepatitis C
- 2/09/05
The Effects of Interferon Alfa-2b on Blood
Platelets
in Patients with Chronic Hepatitis C
- 10/11/04
HIV AND AIDS
|
HEPATITIS B
|
HEPATITIS C
|
HIV / HBV CO-INFECTION
|
HIV / HCV CO-INFECTION
|
HEALTH AND TECHNO
LOGY
|
TESTS
|
INTERNET CONFERENCE REPORTS
|
TELECONFERENCES
|
LINKS
|
ABOUT US
|
CONTACT US